2.1K
JEWe built Scripts to solve a simple problem:
Clinics shouldn’t have to choose between price and quality.
We recently had Dr. Ian Justill Ellis on the Unscripted podcast — a true innovator pushing advanced thinking around GLP-1 protocols and patient optimization. The kind of clinician who studies the science, refines dosing strategies, and cares deeply about long-term outcomes.
That’s who we align with.
Here’s the reality of this industry:
There are groups cutting corners to offer low pricing.
There are others charging premium rates without delivering premium standards.
At Scripts, we’ve proven you don’t have to sacrifice one to get the other.
Because of our scale, we negotiate best-in-class pricing.
Because of our standards, we personally vet our pharmacy partners.
Because of our infrastructure, clinics reduce operational drag while improving reliability.
We are extremely competitive on price.
We just refuse to compromise quality to get there.
If you want the lowest number at any cost, we’re not the platform for you.
If you want elite pricing, elite partners, and long-term scalability — that’s exactly what we do.
Hearing from innovators like Dr. Ellis reinforces why we built Scripts in the first place.
We’re not here to play small.
We’re here to set the bar.
It’s a Scripts takeover.
@jeff.sakamoto
